Services

Partners within automation and IT

At NNE, we understand that the right solution emerges when technical expertise and vendor independence intersect. We work with all major automation systems, standards and technologies, and we are independent of system suppliers.

Offices

NNE in Denmark

We are an independent company delivering expert pharma engineering services to our pharma and biotech customers.

Projects

Modular and flexible design for biotech facility | NNE

It was built as a fast-track project in just 18 months, using modular engineering – including the comprehensive parallel construction and off-site testing of independent process modules.

Projects

Fast-track optimization of API facility | NNE

LEO Pharma is an independent , research-based pharmaceutical company and one of the world’s leading companies within the treatment of dermatological diseases.

TechTalk

Tomorrow’s pharma manufacturing gets flexible

They are extremely portable, featuring built-in air-bearings, and are very compact, requiring around half as much space as a traditional system. quote Closed processes With the module-based concept, it follows that the most critical processes are isolated in independent modules.

TechTalk

Quality by Design - from patient to control strategy | TechTalk

These defined CPPs and material CQAs are either independent or they correlate.

TechTalk

Minimize interference in biomanufacturing | TechTalk

The matrix approach In the matrix layout below  [ii] , LOUs for a process are located in independent , segregated spaces that are operational in a defined sequence for a campaign when needed.

From intern to junior process engineer | NNE

I had the opportunity to work independently as well as interdisciplinary, which helped me to create a network.

TechTalk

High containment becomes high priority in pharma | TechTalk

 Since all process steps are independent of one another, this also minimizes risk to the operator or possible cross-contamination with other products.

TechTalk

Cell and gene therapy: From research to early clinical manufacturing

This means: Defining our own template(s) Developing a manufacturing facility design concept that is highly independent of process research and adaptable for later changes + future flexibility Having the courage to make bold decisions and ensure management will back them up, as not everything is defined and crystal clear from the start Addressing challenge 2: The process for CGT is immature - impacting process and facility design To address the...